Prepare an enteric-coated pellets enquiry and qualify gastro-resistance, the medium transition and later release for the intended dosage form.
R
Rraynex Editorial Team
2 min read
Overview
When sourcing enteric-coated pellets, define the acid-stage and subsequent release objectives before asking a manufacturer for data. The two stages answer separate questions. Record the intended capsule or tablet process so the technical team can decide where gastro-resistance needs to be reassessed.
Establish which material the results describe
Ask for the material name, exact active form, loading basis, batch and sample preparation. Use the same identifiers in the product specification, data report and enquiry. For a comparison involving Esomeprazole EC Pellets or Omeprazole EC (WW), first confirm that the data refer to the proposed catalogue item and chemical form.
Document the transition between stages
Enteric qualification evidence by stage
Stage
Record
Question to resolve
Before the run
Apparatus, amount tested, active reporting basis and method revision
Do both parties mean the same material and test procedure?
Acid stage
Medium, duration, sampling point and gastro-resistance criterion
What happens under the specified acidic conditions?
Transition
How the medium changes and when the next stage starts
Is the later sampling clock comparable between data sets?
Later stage
Medium, time points, acceptance criteria and batch results
Does the material perform as intended under the later conditions?
If one report describes the pellets as supplied and another describes a finished capsule or tablet, retain that distinction in the trial record. Transfer, blending, filling or compaction can change the evaluation required. Define the finished-product tests with the responsible formulation and QA teams. EMA guidance for finished oral modified-release products
Identify when the design needs a separate evaluation
Is an acid-stage result enough for supplier qualification?
Review the acid-stage result, later release data and test method together. Confirm that both stages correspond to the proposed material and intended dosage form.
Can I use a universal acid-stage limit for all EC pellets?
Agree acceptance criteria for the specific material and intended formulation. Record the applicable method and basis with the limit.
Put insight into practice
Let’s discuss your next formulation project.
Share your product, strength, release requirements, expected quantity and destination market with our team.
Evaluate a pharma pellets manufacturer using a supplier qualification checklist for material identity, site scope, sample testing and commercial readiness.